MGX
Metagenomi·NASDAQ
--
--(--)
--
--(--)
5.11 / 10
Netural
Analyst coverage is positive with a 3.02 weighted rating and a majority Strong Buy/Buy stance, indicating confidence in MGX's long-term prospects. Fund flows are similarly constructive, rated 'good' with a 7.2 score, though recent trends show a slight negative bias. Together, analyst conviction and positive liquidity support the fundamental strengths, offsetting some technical weaknesses.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-08-15
InstitutionChardan Capital
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of MGX?
- MGX holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.11/10 (Netural).
